Investigation on the Influencing Factors Related to Quality of Life of Adult Epilepsy Patients in Wenzhou, China, Based on Structural Equation Model

Table 6

Correlation between quality of life and epilepsy conditions in patients with epilepsy.

Items		Seizure anxiety	Life satisfaction	Emotional health	Energy fatigue	Cognitive function	Drug effect	Social activity	Total score
Pathogeny	Inheritance	61.3 ± 28.0	57.4 ± 27.6	64.9 ± 40.4	64.3 ± 28.3	61.3 ± 28.0	57.4 ± 27.6	64.9 ± 40.4	64.3 ± 28.3
	Structure	13.5 ± 4.52	14.0 ± 3.25	13.4 ± 2.94	13.6 ± 4.47	13.5 ± 4.52	14.0 ± 3.25	13.4 ± 2.94	13.6 ± 4.47
	Infected	71.4 ± 14.4	67.8 ± 19.8	74.4 ± 9.20	70.0 ± 16.3	71.4 ± 14.4	67.8 ± 19.8	74.4 ± 9.20	70.0 ± 16.3
	Unknown	46.0 ± 16.0	50.2 ± 16.7	48.8 ± 10.7	51.6 ± 15.9	46.0 ± 16.0	50.2 ± 16.7	48.8 ± 10.7	51.6 ± 15.9
F		0.84	0.474	0.84	0.474	0.84	0.474	0.84	0.474
p		0.19	0.901	0.19	0.901	0.19	0.901	0.19	0.901
Age of onset	≤10	52.6 ± 31.6	59.2 ± 29.7	65.1 ± 24.6	69.4 ± 24.6	52.6 ± 31.6	59.2 ± 29.7	65.1 ± 24.6	69.4 ± 24.6
	11–20	13.6 ± 4.23	13.0 ± 3.89	14.5 ± 3.42	14.5 ± 4.66	13.6 ± 4.23	13.0 ± 3.89	14.5 ± 3.42	14.5 ± 4.66
	21–30	67.3 ± 17.3	69.8 ± 17.7	69.3 ± 17.9	70.5 ± 16.7	67.3 ± 17.3	69.8 ± 17.7	69.3 ± 17.9	70.5 ± 16.7
	≥31	47.1 ± 16.9	51.3 ± 16.4	51.1 ± 14.6	49.9 ± 17.2	47.1 ± 16.9	51.3 ± 16.4	51.1 ± 14.6	49.9 ± 17.2
F		2.22	0.087	2.22	0.087	2.22	0.087	2.22	0.087
p		1.88	0.134	1.88	0.134	1.88	0.134	1.88	0.134
Course of disease	≤5	58.4 ± 29.1	64.6 ± 26.5	60.6 ± 30.5	59.8 ± 27.6	58.4 ± 29.1	64.6 ± 26.5	60.6 ± 30.5	59.8 ± 27.6
	6–10	14.1 ± 3.83	13.3 ± 3.84	14.0 ± 4.48	13.7 ± 3.74	14.1 ± 3.83	13.3 ± 3.84	14.0 ± 4.48	13.7 ± 3.74
	11–20	68.1 ± 16.7	72.8 ± 14.0	70.9 ± 19.5	62.1 ± 19.8	68.1 ± 16.7	72.8 ± 14.0	70.9 ± 19.5	62.1 ± 19.8
	≥21	50.6 ± 15.7	53.0 ± 15.1	50.3 ± 15.6	45.0 ± 18.6	50.6 ± 15.7	53.0 ± 15.1	50.3 ± 15.6	45.0 ± 18.6
F		0.49	0.687	0.49	0.687	0.49	0.687	0.49	0.687
p		0.44	0.722	0.44	0.722	0.44	0.722	0.44	0.722
Seizure types	Simple part	47.4 ± 25.5	55.3 ± 30.0	62.8 ± 28.4	68.7 ± 26.3	68.1 ± 21.9	47.4 ± 25.5	55.3 ± 30.0	62.8 ± 28.4
	Complex part	14.7 ± 5.17	12.9 ± 3.64	13.9 ± 4.06	14.0 ± 4.30	14.2 ± 2.67	14.7 ± 5.17	12.9 ± 3.64	13.9 ± 4.06
	Secondary comprehensiveness	67.2 ± 16.5	68.7 ± 17.3	69.1 ± 18.3	72 ± 13.8	73.0 ± 18.7	67.2 ± 16.5	68.7 ± 17.3	69.1 ± 18.3
	Full-scale attack	48 ± 15.2	49.7 ± 16.5	51.1 ± 16.3	47.6 ± 16.0	54.9 ± 15.3	48 ± 15.2	49.7 ± 16.5	51.1 ± 16.3
	Absence attack	71.1 ± 22.1	73.0 ± 24.1	78.2 ± 26.5	83.8 ± 19.4	76.9 ± 35.9	71.1 ± 22.1	73.0 ± 24.1	78.2 ± 26.5
F		1.70	0.152	1.70	0.152	1.70	0.152	1.70	0.152
p		0.69	0.598	0.69	0.598	0.69	0.598	0.69	0.598
Seizure frequency	>1 time/week	54.0 ± 32.7	47.1 ± 29.6	64.5 ± 26.3	71 ± 23.3	54.0 ± 32.7	47.1 ± 29.6	64.5 ± 26.3	71 ± 23.3
	1 time/week to 1 time/month	12.6 ± 4.20	14.1 ± 3.40	13.8 ± 3.67	13.6 ± 4.59	12.6 ± 4.20	14.1 ± 3.40	13.8 ± 3.67	13.6 ± 4.59
	1 time/month to 1 time/year	63.7 ± 18.3	66.7 ± 19.2	69.4 ± 16.3	72.6 ± 16.5	63.7 ± 18.3	66.7 ± 19.2	69.4 ± 16.3	72.6 ± 16.5
	<1 time/year	47.7 ± 18.9	47.4 ± 16.6	52.9 ± 13.7	51.1 ± 16.9	47.7 ± 18.9	47.4 ± 16.6	52.9 ± 13.7	51.1 ± 16.9
F		8.33	0.000	8.33	0.000	8.33	0.000	8.33	0.000
p		0.58	0.631	0.58	0.631	0.58	0.631	0.58	0.631
No attack months after treatment	≤1 month	48.5 ± 30.2	61.7 ± 26.8	70.8 ± 25.5	67.1 ± 23.7	74.4 ± 22.0	48.5 ± 30.2	61.7 ± 26.8	70.8 ± 25.5
	1–6 months	13.9 ± 3.60	13.5 ± 3.53	13.6 ± 4.86	13.5 ± 4.19	14.0 ± 4.63	13.9 ± 3.60	13.5 ± 3.53	13.6 ± 4.86
	7–12 months	66.2 ± 18.9	70.2 ± 16.5	68.4 ± 15.2	68.4 ± 15.3	75.3 ± 17.6	66.2 ± 18.9	70.2 ± 16.5	68.4 ± 15.2
	13–24 months	47.4 ± 16.8	52.1 ± 13.8	51.5 ± 13.7	50.3 ± 18.5	53.1 ± 16.4	47.4 ± 16.8	52.1 ± 13.8	51.5 ± 13.7
	≥25 months	71.4 ± 25.4	77.9 ± 26.3	83.1 ± 25.6	74.2 ± 24.9	85.6 ± 23.7	71.4 ± 25.4	77.9 ± 26.3	83.1 ± 25.6
F		6.75	0.000	6.75	0.000	6.75	0.000	6.75	0.000
p		0.10	0.981	0.10	0.981	0.10	0.981	0.10	0.981
Intractable	Yes	45.0 ± 28.9	66.0 ± 26.3	45.0 ± 28.9	66.0 ± 26.3	45.0 ± 28.9	66.0 ± 26.3	45.0 ± 28.9	66.0 ± 26.3
	No	13.9 ± 3.58	13.7 ± 4.09	13.9 ± 3.58	13.7 ± 4.09	13.9 ± 3.58	13.7 ± 4.09	13.9 ± 3.58	13.7 ± 4.09
t	4.48	0.000	4.48	0.000	4.48	0.000	4.48	0.000
p	0.34	0.731	0.34	0.731	0.34	0.731	0.34	0.731
Number of drugs used	One	64.8 ± 28.2	60.6 ± 27.3	42.8 ± 31.9	64.8 ± 28.2	60.6 ± 27.3	42.8 ± 31.9	64.8 ± 28.2	60.6 ± 27.3
	Two	14.0 ± 3.55	13.2 ± 4.34	14.6 ± 3.08	14.0 ± 3.55	13.2 ± 4.34	14.6 ± 3.08	14.0 ± 3.55	13.2 ± 4.34
	Three	70.8 ± 16.8	67.9 ± 19.0	69.2 ± 12.7	70.8 ± 16.8	67.9 ± 19.0	69.2 ± 12.7	70.8 ± 16.8	67.9 ± 19.0
F		3.52	0.032	3.52	0.032	3.52	0.032	3.52	0.032
p		1.26	0.286	1.26	0.286	1.26	0.286	1.26	0.286